Attorney Detail Banner
Back to Attorneys
McCaffrey, Meghan

Meghan A. McCaffrey

Partner

meghanmccaffrey@quinnemanuel.com
Direct Tel: +1 202-538-8177, Direct Fax: +1 202-538-8100
Washington, D.C.
Tel: +1 202 538 8000 Fax: +1 202 538 8100

Meghan A. McCaffrey is a partner in Quinn Emanuel’s Washington, D.C. office.  Meghan represents major U.S. and multinational corporations in complex business disputes and multi-billion dollar commercial litigation in federal and state courts throughout the United States.  Ms. McCaffrey’s experience spans a wide range of industries, including the defense, government, pharmaceutical, marine, construction, and consumer products sectors.  Her work has involved handling high-profile matters such as the Fukushima nuclear accident, 9/11 attacks on the World Trade Center, and the BP oil spill in the Gulf of Mexico.  Ms. McCaffrey also has extensive experience conducting, representing and counseling companies, individuals, and senior executives on sensitive internal and government investigations relating to a variety of subjects, including the False Claims Act, the Foreign Corrupt Practices Act (“FCPA”), and other complex civil and criminal matters.  Many of these actions have been featured in major news publications.   

Ms. McCaffrey earned her J.D. with Honors from the University of Texas Law School, where she served as Co-Chair of the International Commercial Arbitration Moot Court team.  She graduated summa cum laude as a University Scholar from the University of Pittsburgh, where she dual majored in History and Political Science.

  • Express Scripts
  • Constellis
  • Triple Canopy
  • ACADEMI
  • Toyobo Co., Ltd.
  • Bovis Lend Lease
  • O’Brien’s Response Management
  • SEACOR Holdings, Inc.
  • Rio Tinto Company
  • Represent Express Scripts, one of the largest pharmacy benefit managers in the U.S., in multiple cases relating to breach of contract, fraud and antitrust claims arising from terminations of compounding and specialty pharmacies from the Express Scripts network.
  • Represent the former CEO of a Fortune 500 company in multiple class actions, regulatory investigations, and congressional hearings relating to the one of the largest cyber security breaches in U.S. history.
  • Represented defense contractor in an action alleging violations of the False Claims Act, breach of contract and fraud based on conduct in Iraq. Successfully secured favorable settlement of all claims in government-intervened action. 
  • Representation of defense contractor in False Claims Act case involving allegations of falsified weapons qualifications in Kabul, Afghanistan, resulting in favorable settlement of all claims.
  • Defense of Toyobo, a major Japanese fiber manufacturer, in federal and state False Claims Act cases arising from the sale of a high-performance fiber used in the manufacture of hundreds of thousands of bullet-resistant vests.
  • Represented and provided crisis management counseling to a multinational company in connection with the Fukushima, Japan nuclear accident.
  • Represented Bovis Lend Lease and secured a favorable outcome in mass tort litigation involving thousands of claims made by emergency workers arising out of the debris removal operations following the terrorist attacks of September 11, 2001.
  • Advised one of the world's largest mineral resource companies on its negotiations with foreign governments and compliance with U.S. laws.
  • Representation of a large U.S. oil-spill cleanup company in connection with Congressional and other government investigations of the Deepwater Horizon accident in the Gulf of Mexico.
  • Defense of the U.S. military's largest suppliers of jet fuel to troops in Afghanistan in a Congressional investigation of alleged corruption in Central Asia and follow-on investigations conducted by foreign authorities.
  • Representation of a large U.S. multinational industrial products company in FCPA investigations regarding operations in China, Mexico, and Turkey.
  • Representation of a multinational pharmaceutical company based in Europe in an investigation of alleged FCPA violations in its Southeast Asia operations.
  • University  of Texas Law
  • (J.D., with honors, 2008)
  • University of Pittsburgh
  • (B.A., summa cum laude, 2005)
The District Bar of Columbia; The State Bar of New York; United States District Court: Southern District of New York, District of Columbia
  • Weil, Gotshal & Manges LLP:
    • Associate, 2008-2014
  • Global Investigations Review, 40 Under 40: The World’s Leading Young Investigations Specialists (2020)
  • Named a “Rising Star” in Health Care by Law360 (2019)
  • University Scholar, awarded to top two percent of graduating class at University of Pittsburgh.
  • How FDA’s Adverse Event Reporting System Impacts Drug Cos., Law360, August 8, 2013.
  • Post-Meningitis Outbreak:  Questioning FDA’s Oversight, Law360, October 15, 2012.
  • Member, American Bar Association – Battle Space and Contingency Procurements Subcommittee
  • Member, International Stability Operations Association